| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 6.93e-06 | 188 | 29 | 5 | GO:0005201 | |
| GeneOntologyMolecularFunction | heparin binding | 7.68e-06 | 192 | 29 | 5 | GO:0008201 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 3.83e-05 | 268 | 29 | 5 | GO:0005539 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 9.27e-05 | 323 | 29 | 5 | GO:1901681 | |
| GeneOntologyMolecularFunction | calcium ion binding | 6.19e-04 | 749 | 29 | 6 | GO:0005509 | |
| GeneOntologyMolecularFunction | growth factor binding | 1.47e-03 | 156 | 29 | 3 | GO:0019838 | |
| GeneOntologyMolecularFunction | integrin binding | 2.04e-03 | 175 | 29 | 3 | GO:0005178 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | 1.97e-06 | 1141 | 29 | 10 | GO:0045597 | |
| GeneOntologyBiologicalProcess | axon guidance | 2.40e-06 | 285 | 29 | 6 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 2.45e-06 | 286 | 29 | 6 | GO:0097485 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation | 1.57e-05 | 603 | 29 | 7 | GO:0050673 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | 1.60e-05 | 850 | 29 | 8 | GO:0071363 | |
| GeneOntologyBiologicalProcess | response to growth factor | 2.10e-05 | 883 | 29 | 8 | GO:0070848 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | 2.34e-05 | 1186 | 29 | 9 | GO:0007167 | |
| GeneOntologyBiologicalProcess | gliogenesis | 2.68e-05 | 435 | 29 | 6 | GO:0042063 | |
| GeneOntologyBiologicalProcess | positive regulation of epithelial cell proliferation | 3.40e-05 | 270 | 29 | 5 | GO:0050679 | |
| GeneOntologyBiologicalProcess | regulation of low-density lipoprotein particle receptor catabolic process | 3.99e-05 | 7 | 29 | 2 | GO:0032803 | |
| GeneOntologyBiologicalProcess | low-density lipoprotein particle receptor catabolic process | 3.99e-05 | 7 | 29 | 2 | GO:0032802 | |
| GeneOntologyBiologicalProcess | low-density lipoprotein receptor particle metabolic process | 3.99e-05 | 7 | 29 | 2 | GO:0032799 | |
| GeneOntologyBiologicalProcess | negative regulation of monocyte chemotaxis | 3.99e-05 | 7 | 29 | 2 | GO:0090027 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 4.75e-05 | 482 | 29 | 6 | GO:0007178 | |
| GeneOntologyBiologicalProcess | ERBB2-EGFR signaling pathway | 5.32e-05 | 8 | 29 | 2 | GO:0038134 | |
| GeneOntologyBiologicalProcess | cerebral cortex cell migration | 6.59e-05 | 56 | 29 | 3 | GO:0021795 | |
| GeneOntologyBiologicalProcess | regulation of epithelial cell proliferation | 6.78e-05 | 514 | 29 | 6 | GO:0050678 | |
| GeneOntologyBiologicalProcess | glial cell differentiation | 7.73e-05 | 321 | 29 | 5 | GO:0010001 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | 9.65e-05 | 802 | 29 | 7 | GO:0048812 | |
| GeneOntologyBiologicalProcess | regulation of basement membrane organization | 1.04e-04 | 11 | 29 | 2 | GO:0110011 | |
| GeneOntologyBiologicalProcess | embryo development | 1.05e-04 | 1437 | 29 | 9 | GO:0009790 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | 1.10e-04 | 819 | 29 | 7 | GO:0120039 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1.12e-04 | 347 | 29 | 5 | GO:0090092 | |
| GeneOntologyBiologicalProcess | axonogenesis | 1.15e-04 | 566 | 29 | 6 | GO:0007409 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | 1.16e-04 | 826 | 29 | 7 | GO:0048858 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | 1.17e-04 | 1125 | 29 | 8 | GO:0035239 | |
| GeneOntologyBiologicalProcess | negative regulation of multicellular organismal process | 1.38e-04 | 1488 | 29 | 9 | GO:0051241 | |
| GeneOntologyBiologicalProcess | telencephalon cell migration | 1.40e-04 | 72 | 29 | 3 | GO:0022029 | |
| GeneOntologyBiologicalProcess | forebrain cell migration | 1.58e-04 | 75 | 29 | 3 | GO:0021885 | |
| GeneOntologyBiologicalProcess | positive regulation of integrin-mediated signaling pathway | 1.72e-04 | 14 | 29 | 2 | GO:2001046 | |
| GeneOntologyBiologicalProcess | regulation of receptor catabolic process | 1.72e-04 | 14 | 29 | 2 | GO:2000644 | |
| GeneOntologyBiologicalProcess | central nervous system development | 1.80e-04 | 1197 | 29 | 8 | GO:0007417 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | 1.88e-04 | 619 | 29 | 6 | GO:0002009 | |
| GeneOntologyBiologicalProcess | mammary gland epithelium development | 2.21e-04 | 84 | 29 | 3 | GO:0061180 | |
| GeneOntologyBiologicalProcess | axon development | 2.29e-04 | 642 | 29 | 6 | GO:0061564 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 2.48e-04 | 412 | 29 | 5 | GO:0090287 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | 2.69e-04 | 1269 | 29 | 8 | GO:0009887 | |
| GeneOntologyBiologicalProcess | neuron projection development | 2.93e-04 | 1285 | 29 | 8 | GO:0031175 | |
| GeneOntologyBiologicalProcess | metanephros development | 3.17e-04 | 95 | 29 | 3 | GO:0001656 | |
| GeneOntologyBiologicalProcess | regulation of chemotaxis | 3.49e-04 | 242 | 29 | 4 | GO:0050920 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 3.54e-04 | 445 | 29 | 5 | GO:0141091 | |
| GeneOntologyBiologicalProcess | regulation of locomotion | 3.65e-04 | 1327 | 29 | 8 | GO:0040012 | |
| GeneOntologyBiologicalProcess | regulation of plasma lipoprotein particle levels | 4.02e-04 | 103 | 29 | 3 | GO:0097006 | |
| GeneOntologyBiologicalProcess | regeneration | 4.06e-04 | 252 | 29 | 4 | GO:0031099 | |
| GeneOntologyBiologicalProcess | axon extension involved in axon guidance | 4.33e-04 | 22 | 29 | 2 | GO:0048846 | |
| GeneOntologyBiologicalProcess | neuron projection extension involved in neuron projection guidance | 4.33e-04 | 22 | 29 | 2 | GO:1902284 | |
| GeneOntologyBiologicalProcess | regulation of integrin-mediated signaling pathway | 4.74e-04 | 23 | 29 | 2 | GO:2001044 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte chemotaxis | 4.74e-04 | 23 | 29 | 2 | GO:0002689 | |
| GeneOntologyBiologicalProcess | positive regulation of locomotion | 4.97e-04 | 742 | 29 | 6 | GO:0040017 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | 5.18e-04 | 748 | 29 | 6 | GO:0048667 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | 5.26e-04 | 750 | 29 | 6 | GO:0048729 | |
| GeneOntologyBiologicalProcess | tube development | 5.28e-04 | 1402 | 29 | 8 | GO:0035295 | |
| GeneOntologyBiologicalProcess | positive regulation of Ras protein signal transduction | 5.61e-04 | 25 | 29 | 2 | GO:0046579 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | 5.88e-04 | 1077 | 29 | 7 | GO:0098609 | |
| GeneOntologyBiologicalProcess | ERBB2 signaling pathway | 6.56e-04 | 27 | 29 | 2 | GO:0038128 | |
| GeneOntologyBiologicalProcess | positive regulation of neuron differentiation | 6.75e-04 | 123 | 29 | 3 | GO:0045666 | |
| GeneOntologyBiologicalProcess | neuron development | 7.01e-04 | 1463 | 29 | 8 | GO:0048666 | |
| GeneOntologyBiologicalProcess | regulation of cell growth | 7.13e-04 | 519 | 29 | 5 | GO:0001558 | |
| GeneOntologyBiologicalProcess | metanephros morphogenesis | 7.57e-04 | 29 | 29 | 2 | GO:0003338 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelial fold | 7.57e-04 | 29 | 29 | 2 | GO:0060571 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | 8.24e-04 | 817 | 29 | 6 | GO:0048514 | |
| GeneOntologyBiologicalProcess | receptor catabolic process | 8.65e-04 | 31 | 29 | 2 | GO:0032801 | |
| GeneOntologyBiologicalProcess | regulation of monocyte chemotaxis | 9.22e-04 | 32 | 29 | 2 | GO:0090025 | |
| GeneOntologyBiologicalProcess | epidermal growth factor receptor signaling pathway | 9.63e-04 | 139 | 29 | 3 | GO:0007173 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | 1.08e-03 | 1194 | 29 | 7 | GO:0000902 | |
| GeneOntologyBiologicalProcess | motor neuron axon guidance | 1.10e-03 | 35 | 29 | 2 | GO:0008045 | |
| GeneOntologyBiologicalProcess | cerebral cortex development | 1.13e-03 | 147 | 29 | 3 | GO:0021987 | |
| GeneOntologyBiologicalProcess | embryonic skeletal system development | 1.15e-03 | 148 | 29 | 3 | GO:0048706 | |
| GeneOntologyBiologicalProcess | plasma lipoprotein particle remodeling | 1.17e-03 | 36 | 29 | 2 | GO:0034369 | |
| GeneOntologyBiologicalProcess | protein-lipid complex remodeling | 1.17e-03 | 36 | 29 | 2 | GO:0034368 | |
| GeneOntologyBiologicalProcess | negative regulation of cell differentiation | 1.18e-03 | 875 | 29 | 6 | GO:0045596 | |
| GeneOntologyBiologicalProcess | regulation of cell migration | 1.18e-03 | 1211 | 29 | 7 | GO:0030334 | |
| GeneOntologyBiologicalProcess | negative regulation of developmental process | 1.23e-03 | 1220 | 29 | 7 | GO:0051093 | |
| GeneOntologyBiologicalProcess | digestive tract development | 1.25e-03 | 152 | 29 | 3 | GO:0048565 | |
| GeneOntologyBiologicalProcess | salivary gland morphogenesis | 1.30e-03 | 38 | 29 | 2 | GO:0007435 | |
| GeneOntologyBiologicalProcess | negative regulation of mononuclear cell migration | 1.37e-03 | 39 | 29 | 2 | GO:0071676 | |
| GeneOntologyBiologicalProcess | protein-containing complex remodeling | 1.37e-03 | 39 | 29 | 2 | GO:0034367 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | 1.41e-03 | 906 | 29 | 6 | GO:0043009 | |
| GeneOntologyBiologicalProcess | ERBB signaling pathway | 1.44e-03 | 160 | 29 | 3 | GO:0038127 | |
| GeneOntologyBiologicalProcess | mammary gland development | 1.50e-03 | 162 | 29 | 3 | GO:0030879 | |
| GeneOntologyBiologicalProcess | phagocytosis, recognition | 1.59e-03 | 42 | 29 | 2 | GO:0006910 | |
| GeneOntologyBiologicalProcess | blood vessel development | 1.60e-03 | 929 | 29 | 6 | GO:0001568 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | 1.60e-03 | 929 | 29 | 6 | GO:0009792 | |
| GeneOntologyBiologicalProcess | positive regulation of chemotaxis | 1.60e-03 | 166 | 29 | 3 | GO:0050921 | |
| GeneOntologyBiologicalProcess | regulation of cell motility | 1.63e-03 | 1280 | 29 | 7 | GO:2000145 | |
| GeneOntologyBiologicalProcess | digestive system development | 1.63e-03 | 167 | 29 | 3 | GO:0055123 | |
| GeneOntologyBiologicalProcess | cell growth | 1.63e-03 | 625 | 29 | 5 | GO:0016049 | |
| GeneOntologyCellularComponent | extracellular matrix | 2.21e-07 | 656 | 30 | 9 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 2.27e-07 | 658 | 30 | 9 | GO:0030312 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 5.80e-07 | 530 | 30 | 8 | GO:0062023 | |
| GeneOntologyCellularComponent | keratin filament | 1.09e-05 | 97 | 30 | 4 | GO:0045095 | |
| GeneOntologyCellularComponent | basement membrane | 2.69e-05 | 122 | 30 | 4 | GO:0005604 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 2.67e-04 | 17 | 30 | 2 | GO:0098637 | |
| GeneOntologyCellularComponent | intermediate filament | 2.97e-04 | 227 | 30 | 4 | GO:0005882 | |
| GeneOntologyCellularComponent | Golgi lumen | 5.05e-04 | 109 | 30 | 3 | GO:0005796 | |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | 5.19e-04 | 263 | 30 | 4 | GO:0045111 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 3.24e-03 | 59 | 30 | 2 | GO:0098636 | |
| GeneOntologyCellularComponent | cell surface | 4.40e-03 | 1111 | 30 | 6 | GO:0009986 | |
| HumanPheno | Alveolar cell carcinoma | 6.01e-06 | 18 | 11 | 3 | HP:0006519 | |
| HumanPheno | Neoplasm of the tracheobronchial system | 1.13e-05 | 22 | 11 | 3 | HP:0100552 | |
| HumanPheno | Horizontal eyebrow | 4.32e-05 | 34 | 11 | 3 | HP:0011228 | |
| HumanPheno | Abnormal lacrimal duct morphology | 1.39e-04 | 50 | 11 | 3 | HP:0011481 | |
| MousePheno | microphthalmia | 1.26e-06 | 362 | 23 | 7 | MP:0001297 | |
| MousePheno | abnormal eye size | 1.60e-06 | 375 | 23 | 7 | MP:0002697 | |
| MousePheno | abnormal Schwann cell morphology | 2.91e-05 | 37 | 23 | 3 | MP:0001106 | |
| MousePheno | abnormal PNS glial cell morphology | 2.91e-05 | 37 | 23 | 3 | MP:0001105 | |
| MousePheno | abnormal respiration | 3.41e-05 | 598 | 23 | 7 | MP:0001943 | |
| MousePheno | abnormal basement membrane morphology | 3.69e-05 | 40 | 23 | 3 | MP:0004272 | |
| MousePheno | abnormal blood vessel morphology | 5.12e-05 | 1472 | 23 | 10 | MP:0001614 | |
| MousePheno | abnormal submandibular gland development | 5.41e-05 | 7 | 23 | 2 | MP:0013541 | |
| MousePheno | cleft palate | 9.04e-05 | 289 | 23 | 5 | MP:0000111 | |
| MousePheno | oral cleft | 9.34e-05 | 291 | 23 | 5 | MP:0021164 | |
| MousePheno | limbs/digits/tail phenotype | 9.59e-05 | 1258 | 23 | 9 | MP:0005371 | |
| MousePheno | abnormal ureteric bud morphology | 1.07e-04 | 57 | 23 | 3 | MP:0006032 | |
| MousePheno | abnormal pectoral girdle bone morphology | 1.10e-04 | 301 | 23 | 5 | MP:0004508 | |
| MousePheno | eyelids open at birth | 1.13e-04 | 58 | 23 | 3 | MP:0001302 | |
| MousePheno | petechiae | 1.41e-04 | 11 | 23 | 2 | MP:0008816 | |
| MousePheno | abnormal palate morphology | 1.48e-04 | 321 | 23 | 5 | MP:0003755 | |
| MousePheno | abnormal limb morphology | 1.50e-04 | 1028 | 23 | 8 | MP:0002109 | |
| MousePheno | absent eyelids | 1.69e-04 | 12 | 23 | 2 | MP:0001341 | |
| MousePheno | abnormal vein morphology | 1.78e-04 | 176 | 23 | 4 | MP:0002725 | |
| MousePheno | abnormal heart ventricle morphology | 2.03e-04 | 793 | 23 | 7 | MP:0005294 | |
| MousePheno | abnormal cranium morphology | 2.36e-04 | 813 | 23 | 7 | MP:0000438 | |
| MousePheno | abnormal digestive system development | 2.43e-04 | 75 | 23 | 3 | MP:0003119 | |
| MousePheno | abnormal craniofacial bone morphology | 2.63e-04 | 827 | 23 | 7 | MP:0002116 | |
| MousePheno | abnormal hindlimb morphology | 2.64e-04 | 576 | 23 | 6 | MP:0000556 | |
| MousePheno | abnormal heart development | 2.94e-04 | 372 | 23 | 5 | MP:0000267 | |
| MousePheno | abnormal chondrocyte morphology | 3.28e-04 | 83 | 23 | 3 | MP:0000166 | |
| MousePheno | abnormal joint mobility | 3.47e-04 | 17 | 23 | 2 | MP:0008069 | |
| MousePheno | abnormal autopod morphology | 3.66e-04 | 390 | 23 | 5 | MP:0000572 | |
| MousePheno | abnormal respiratory function | 4.06e-04 | 399 | 23 | 5 | MP:0002327 | |
| MousePheno | abnormal appendicular skeleton morphology | 4.29e-04 | 896 | 23 | 7 | MP:0009250 | |
| MousePheno | abnormal respiratory system physiology | 4.32e-04 | 897 | 23 | 7 | MP:0002133 | |
| MousePheno | abnormal sensory neuron innervation pattern | 4.44e-04 | 92 | 23 | 3 | MP:0000968 | |
| MousePheno | abnormal aorta morphology | 4.55e-04 | 225 | 23 | 4 | MP:0000272 | |
| MousePheno | abnormal kidney development | 4.58e-04 | 93 | 23 | 3 | MP:0000527 | |
| MousePheno | exencephaly | 4.94e-04 | 230 | 23 | 4 | MP:0000914 | |
| MousePheno | abnormal heart ventricle outflow tract morphology | 5.03e-04 | 96 | 23 | 3 | MP:0010224 | |
| MousePheno | abnormal cranium size | 5.19e-04 | 97 | 23 | 3 | MP:0010031 | |
| MousePheno | abnormal eyelid morphology | 5.19e-04 | 233 | 23 | 4 | MP:0001340 | |
| MousePheno | flaky skin | 5.34e-04 | 21 | 23 | 2 | MP:0001195 | |
| MousePheno | abnormal extracellular matrix morphology | 5.67e-04 | 100 | 23 | 3 | MP:0013258 | |
| MousePheno | abnormal glossopharyngeal nerve morphology | 5.86e-04 | 22 | 23 | 2 | MP:0001073 | |
| MousePheno | abnormal artery morphology | 6.35e-04 | 440 | 23 | 5 | MP:0002191 | |
| MousePheno | abnormal axon fasciculation | 6.42e-04 | 23 | 23 | 2 | MP:0009450 | |
| MousePheno | abnormal sternum morphology | 7.29e-04 | 255 | 23 | 4 | MP:0000157 | |
| MousePheno | abnormal urinary system development | 7.69e-04 | 111 | 23 | 3 | MP:0003942 | |
| MousePheno | abnormal submandibular gland morphology | 8.22e-04 | 26 | 23 | 2 | MP:0003793 | |
| MousePheno | abnormal ear morphology | 8.57e-04 | 470 | 23 | 5 | MP:0002102 | |
| MousePheno | abnormal cardinal vein morphology | 9.54e-04 | 28 | 23 | 2 | MP:0004783 | |
| MousePheno | abnormal coronary artery morphology | 1.02e-03 | 29 | 23 | 2 | MP:0004111 | |
| MousePheno | abnormal vagus nerve morphology | 1.02e-03 | 29 | 23 | 2 | MP:0001074 | |
| MousePheno | delayed bone ossification | 1.14e-03 | 127 | 23 | 3 | MP:0000060 | |
| MousePheno | abnormal heartbeat | 1.14e-03 | 501 | 23 | 5 | MP:0004085 | |
| MousePheno | perinatal lethality, incomplete penetrance | 1.16e-03 | 503 | 23 | 5 | MP:0011090 | |
| MousePheno | abnormal thoracic aorta morphology | 1.33e-03 | 134 | 23 | 3 | MP:0010468 | |
| MousePheno | abnormal bronchus morphology | 1.33e-03 | 33 | 23 | 2 | MP:0002264 | |
| MousePheno | thin epidermis | 1.33e-03 | 33 | 23 | 2 | MP:0001218 | |
| MousePheno | abnormal systemic artery morphology | 1.40e-03 | 304 | 23 | 4 | MP:0011655 | |
| MousePheno | small pancreas | 1.41e-03 | 34 | 23 | 2 | MP:0004247 | |
| MousePheno | abnormal branching involved in lung morphogenesis | 1.41e-03 | 34 | 23 | 2 | MP:0011024 | |
| MousePheno | abnormal jaw morphology | 1.47e-03 | 530 | 23 | 5 | MP:0000454 | |
| MousePheno | prolonged RR interval | 1.47e-03 | 139 | 23 | 3 | MP:0010506 | |
| MousePheno | abnormal limb development | 1.50e-03 | 140 | 23 | 3 | MP:0006279 | |
| MousePheno | abnormal muscle morphology | 1.51e-03 | 1106 | 23 | 7 | MP:0002108 | |
| MousePheno | abnormal lung development | 1.57e-03 | 142 | 23 | 3 | MP:0001176 | |
| MousePheno | abnormal axial skeleton morphology | 1.60e-03 | 1458 | 23 | 8 | MP:0002114 | |
| MousePheno | small snout | 1.63e-03 | 144 | 23 | 3 | MP:0030190 | |
| MousePheno | abnormal joint physiology | 1.66e-03 | 145 | 23 | 3 | MP:0031169 | |
| MousePheno | abnormal major salivary gland morphology | 1.67e-03 | 37 | 23 | 2 | MP:0003792 | |
| MousePheno | perinatal lethality | 1.71e-03 | 1130 | 23 | 7 | MP:0002081 | |
| MousePheno | preaxial polydactyly | 1.85e-03 | 39 | 23 | 2 | MP:0009743 | |
| MousePheno | abnormal chest morphology | 1.85e-03 | 39 | 23 | 2 | MP:0004134 | |
| MousePheno | abnormal body wall morphology | 1.87e-03 | 151 | 23 | 3 | MP:0003385 | |
| MousePheno | decreased hair follicle number | 2.04e-03 | 41 | 23 | 2 | MP:0000379 | |
| MousePheno | increased compact bone thickness | 2.04e-03 | 41 | 23 | 2 | MP:0004148 | |
| MousePheno | abnormal heart right ventricle morphology | 2.05e-03 | 156 | 23 | 3 | MP:0003920 | |
| MousePheno | abnormal interventricular septum morphology | 2.16e-03 | 342 | 23 | 4 | MP:0000281 | |
| MousePheno | abnormal respiratory system development | 2.20e-03 | 160 | 23 | 3 | MP:0003115 | |
| MousePheno | abnormal RR interval | 2.20e-03 | 160 | 23 | 3 | MP:0010504 | |
| MousePheno | increased variability of skeletal muscle fiber size | 2.24e-03 | 43 | 23 | 2 | MP:0009403 | |
| MousePheno | abnormal heart valve morphology | 2.32e-03 | 163 | 23 | 3 | MP:0000285 | |
| MousePheno | impaired lung alveolus development | 2.35e-03 | 44 | 23 | 2 | MP:0006027 | |
| MousePheno | respiratory failure | 2.40e-03 | 165 | 23 | 3 | MP:0001953 | |
| MousePheno | abnormal viscerocranium morphology | 2.41e-03 | 593 | 23 | 5 | MP:0005274 | |
| MousePheno | abnormal skin adnexa physiology | 2.49e-03 | 167 | 23 | 3 | MP:0010680 | |
| MousePheno | decreased respiration | 2.62e-03 | 170 | 23 | 3 | MP:0014274 | |
| MousePheno | transposition of great arteries | 2.68e-03 | 47 | 23 | 2 | MP:0004110 | |
| MousePheno | abnormal vestibular hair cell morphology | 2.79e-03 | 48 | 23 | 2 | MP:0002623 | |
| MousePheno | abnormal digestive system morphology | 2.83e-03 | 1233 | 23 | 7 | MP:0000462 | |
| MousePheno | abnormal lung alveolus development | 3.02e-03 | 50 | 23 | 2 | MP:0010995 | |
| MousePheno | narrow eye opening | 3.02e-03 | 50 | 23 | 2 | MP:0005287 | |
| Domain | Growth_fac_rcpt_ | 2.16e-14 | 156 | 29 | 10 | IPR009030 | |
| Domain | EGF | BRINP2 LAMA2 LAMB1 SLIT2 HSPG2 FRAS1 MEGF6 MEGF8 ADGRE3 PEAR1 | 1.33e-12 | 235 | 29 | 10 | SM00181 |
| Domain | Laminin_EGF | 1.27e-11 | 35 | 29 | 6 | PF00053 | |
| Domain | EGF_Lam | 1.27e-11 | 35 | 29 | 6 | SM00180 | |
| Domain | Laminin_EGF | 2.15e-11 | 38 | 29 | 6 | IPR002049 | |
| Domain | EGF-like_dom | 9.14e-11 | 249 | 29 | 9 | IPR000742 | |
| Domain | VWFC_1 | 2.29e-09 | 36 | 29 | 5 | PS01208 | |
| Domain | VWC | 3.04e-09 | 38 | 29 | 5 | SM00214 | |
| Domain | VWFC_2 | 3.04e-09 | 38 | 29 | 5 | PS50184 | |
| Domain | VWF_dom | 5.13e-09 | 42 | 29 | 5 | IPR001007 | |
| Domain | Furin_repeat | 1.41e-08 | 18 | 29 | 4 | IPR006212 | |
| Domain | FU | 1.41e-08 | 18 | 29 | 4 | SM00261 | |
| Domain | VWC | 9.35e-08 | 28 | 29 | 4 | PF00093 | |
| Domain | EGF_1 | 9.84e-08 | 255 | 29 | 7 | PS00022 | |
| Domain | EGF-like_CS | 1.15e-07 | 261 | 29 | 7 | IPR013032 | |
| Domain | EGF_LAM_2 | 1.25e-07 | 30 | 29 | 4 | PS50027 | |
| Domain | EGF_LAM_1 | 1.25e-07 | 30 | 29 | 4 | PS01248 | |
| Domain | EGF_2 | 1.28e-07 | 265 | 29 | 7 | PS01186 | |
| Domain | Laminin_G_1 | 5.51e-07 | 11 | 29 | 3 | PF00054 | |
| Domain | EGF_CA | 1.15e-06 | 122 | 29 | 5 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.24e-06 | 124 | 29 | 5 | IPR001881 | |
| Domain | EGF_3 | 1.39e-06 | 235 | 29 | 6 | PS50026 | |
| Domain | VWFD | 1.86e-06 | 16 | 29 | 3 | PS51233 | |
| Domain | VWD | 1.86e-06 | 16 | 29 | 3 | SM00216 | |
| Domain | VWF_type-D | 1.86e-06 | 16 | 29 | 3 | IPR001846 | |
| Domain | VWD | 1.86e-06 | 16 | 29 | 3 | PF00094 | |
| Domain | CTCK_1 | 2.70e-06 | 18 | 29 | 3 | PS01185 | |
| Domain | VWC_out | 3.21e-06 | 19 | 29 | 3 | SM00215 | |
| Domain | CT | 5.08e-06 | 22 | 29 | 3 | SM00041 | |
| Domain | Cys_knot_C | 7.57e-06 | 25 | 29 | 3 | IPR006207 | |
| Domain | CTCK_2 | 7.57e-06 | 25 | 29 | 3 | PS01225 | |
| Domain | Tyr_kinase_EGF/ERB/XmrK_rcpt | 1.39e-05 | 4 | 29 | 2 | IPR016245 | |
| Domain | EGF_Ca-bd_CS | 1.47e-05 | 97 | 29 | 4 | IPR018097 | |
| Domain | EGF_CA | 1.59e-05 | 99 | 29 | 4 | PS01187 | |
| Domain | ASX_HYDROXYL | 1.66e-05 | 100 | 29 | 4 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 2.09e-05 | 106 | 29 | 4 | IPR000152 | |
| Domain | LAM_G_DOMAIN | 2.74e-05 | 38 | 29 | 3 | PS50025 | |
| Domain | Keratin_B2_2 | 2.96e-05 | 39 | 29 | 3 | PF13885 | |
| Domain | Laminin_G_2 | 3.20e-05 | 40 | 29 | 3 | PF02210 | |
| Domain | GF_recep_IV | 3.48e-05 | 6 | 29 | 2 | PF14843 | |
| Domain | GF_recep_IV | 3.48e-05 | 6 | 29 | 2 | IPR032778 | |
| Domain | LamG | 4.27e-05 | 44 | 29 | 3 | SM00282 | |
| Domain | Furin-like | 4.87e-05 | 7 | 29 | 2 | PF00757 | |
| Domain | Rcpt_L-dom | 4.87e-05 | 7 | 29 | 2 | IPR000494 | |
| Domain | Furin-like_Cys-rich_dom | 4.87e-05 | 7 | 29 | 2 | IPR006211 | |
| Domain | Recep_L_domain | 4.87e-05 | 7 | 29 | 2 | PF01030 | |
| Domain | - | 4.87e-05 | 7 | 29 | 2 | 3.80.20.20 | |
| Domain | LAMININ_IVA | 6.48e-05 | 8 | 29 | 2 | PS51115 | |
| Domain | Laminin_B | 6.48e-05 | 8 | 29 | 2 | PF00052 | |
| Domain | LamB | 6.48e-05 | 8 | 29 | 2 | SM00281 | |
| Domain | Laminin_IV | 6.48e-05 | 8 | 29 | 2 | IPR000034 | |
| Domain | Laminin_G | 9.81e-05 | 58 | 29 | 3 | IPR001791 | |
| Domain | KAP | 9.81e-05 | 58 | 29 | 3 | IPR002494 | |
| Domain | Unchr_dom_Cys-rich | 1.80e-04 | 13 | 29 | 2 | IPR014853 | |
| Domain | C8 | 1.80e-04 | 13 | 29 | 2 | SM00832 | |
| Domain | TIL_dom | 2.09e-04 | 14 | 29 | 2 | IPR002919 | |
| Domain | Glyco_hormone_CN | 2.41e-04 | 15 | 29 | 2 | IPR006208 | |
| Domain | Cys_knot | 2.41e-04 | 15 | 29 | 2 | PF00007 | |
| Domain | LAMININ_NTER | 2.76e-04 | 16 | 29 | 2 | PS51117 | |
| Domain | Laminin_N | 2.76e-04 | 16 | 29 | 2 | PF00055 | |
| Domain | EMI_domain | 2.76e-04 | 16 | 29 | 2 | IPR011489 | |
| Domain | Laminin_N | 2.76e-04 | 16 | 29 | 2 | IPR008211 | |
| Domain | LamNT | 2.76e-04 | 16 | 29 | 2 | SM00136 | |
| Domain | EMI | 3.12e-04 | 17 | 29 | 2 | PS51041 | |
| Domain | EGF_CA | 3.16e-04 | 86 | 29 | 3 | PF07645 | |
| Domain | Galactose-bd-like | 4.10e-04 | 94 | 29 | 3 | IPR008979 | |
| Domain | - | 4.23e-04 | 95 | 29 | 3 | 2.60.120.200 | |
| Domain | hEGF | 8.58e-04 | 28 | 29 | 2 | PF12661 | |
| Domain | EGF | 9.64e-04 | 126 | 29 | 3 | PF00008 | |
| Domain | Keratin_B2 | 1.75e-03 | 40 | 29 | 2 | PF01500 | |
| Domain | ConA-like_dom | 4.64e-03 | 219 | 29 | 3 | IPR013320 | |
| Domain | - | 5.71e-03 | 73 | 29 | 2 | 2.60.120.260 | |
| Domain | TyrKc | 8.20e-03 | 88 | 29 | 2 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 8.20e-03 | 88 | 29 | 2 | IPR020635 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 5.70e-07 | 46 | 21 | 4 | M239 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 2.47e-06 | 66 | 21 | 4 | MM15925 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_RSV_ATTACHMENT_AND_ENTRY | 4.95e-06 | 23 | 21 | 3 | M48234 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.13e-05 | 30 | 21 | 3 | M27216 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | LAMA2 LAMB1 SLIT2 FGF10 ERBB2 EGFR KRTAP10-1 FURIN KRTAP10-6 KRTAP10-8 | 1.40e-05 | 1432 | 21 | 10 | M509 |
| Pathway | KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_EGF_JAK_STAT_SIGNALING_PATHWAY | 4.42e-05 | 7 | 21 | 2 | M47431 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 6.80e-05 | 502 | 21 | 6 | MM14537 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RTK_PLCG_ITPR_SIGNALING_PATHWAY | 7.11e-05 | 55 | 21 | 3 | M47952 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 8.78e-05 | 59 | 21 | 3 | M27218 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 9.39e-05 | 532 | 21 | 6 | M27870 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 9.48e-05 | 325 | 21 | 5 | M12868 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 1.15e-04 | 11 | 21 | 2 | M158 | |
| Pathway | REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING | 1.15e-04 | 11 | 21 | 2 | MM15478 | |
| Pathway | KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 1.38e-04 | 12 | 21 | 2 | M47393 | |
| Pathway | WP_FOCAL_ADHESION | 1.50e-04 | 187 | 21 | 4 | MM15913 | |
| Pathway | REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING | 1.63e-04 | 13 | 21 | 2 | M27729 | |
| Pathway | REACTOME_ERBB2_REGULATES_CELL_MOTILITY | 1.63e-04 | 13 | 21 | 2 | MM15320 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.87e-04 | 76 | 21 | 3 | M27219 | |
| Pathway | REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING | 1.90e-04 | 14 | 21 | 2 | MM14761 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING | 1.90e-04 | 14 | 21 | 2 | MM14531 | |
| Pathway | WP_FOCAL_ADHESION | 1.91e-04 | 199 | 21 | 4 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 1.91e-04 | 199 | 21 | 4 | M7253 | |
| Pathway | PID_ERBB_NETWORK_PATHWAY | 2.19e-04 | 15 | 21 | 2 | M201 | |
| Pathway | REACTOME_ERBB2_REGULATES_CELL_MOTILITY | 2.19e-04 | 15 | 21 | 2 | M27608 | |
| Pathway | REACTOME_TFAP2_AP_2_FAMILY_REGULATES_TRANSCRIPTION_OF_GROWTH_FACTORS_AND_THEIR_RECEPTORS | 2.19e-04 | 15 | 21 | 2 | M27766 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 2.34e-04 | 82 | 21 | 3 | MM15922 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER | 2.42e-04 | 83 | 21 | 3 | M27163 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GF_RTK_PI3K_SIGNALING_PATHWAY | 2.42e-04 | 83 | 21 | 3 | M47961 | |
| Pathway | REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING | 2.50e-04 | 16 | 21 | 2 | M562 | |
| Pathway | REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING | 2.50e-04 | 16 | 21 | 2 | M570 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2_ECD_MUTANTS | 2.50e-04 | 16 | 21 | 2 | M29847 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_ERBB2_RAS_ERK_SIGNALING_PATHWAY | 2.50e-04 | 16 | 21 | 2 | M47381 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 2.51e-04 | 84 | 21 | 3 | M7098 | |
| Pathway | REACTOME_KERATINIZATION | 2.66e-04 | 217 | 21 | 4 | M27640 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GF_RTK_RAS_PI3K_SIGNALING_PATHWAY | 2.98e-04 | 89 | 21 | 3 | M47963 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 3.07e-04 | 418 | 21 | 5 | MM15587 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GF_RTK_RAS_ERK_SIGNALING_PATHWAY | 3.29e-04 | 92 | 21 | 3 | M47927 | |
| Pathway | REACTOME_ATTACHMENT_AND_ENTRY | 3.56e-04 | 19 | 21 | 2 | M41729 | |
| Pathway | WP_BMP_SIGNALING_PATHWAY_IN_EYELID_DEVELOPMENT | 3.95e-04 | 20 | 21 | 2 | MM15907 | |
| Pathway | WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT | 3.95e-04 | 20 | 21 | 2 | M39624 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING | 4.80e-04 | 22 | 21 | 2 | M26929 | |
| Pathway | BIOCARTA_HER2_PATHWAY | 5.25e-04 | 23 | 21 | 2 | MM1480 | |
| Pathway | BIOCARTA_HER2_PATHWAY | 5.25e-04 | 23 | 21 | 2 | M18719 | |
| Pathway | REACTOME_PI3K_AKT_SIGNALING_IN_CANCER | 5.55e-04 | 110 | 21 | 3 | M27162 | |
| Pathway | BIOCARTA_TFF_PATHWAY | 5.72e-04 | 24 | 21 | 2 | M15926 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | 6.00e-04 | 113 | 21 | 3 | MM14783 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_UBIQUITINATION_OF_RTK_BY_CBL | 6.21e-04 | 25 | 21 | 2 | M47934 | |
| Pathway | WP_SPINAL_CORD_INJURY | 6.64e-04 | 117 | 21 | 3 | M39341 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2_IN_CANCER | 6.72e-04 | 26 | 21 | 2 | M29535 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING | 6.72e-04 | 26 | 21 | 2 | MM15501 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | 6.81e-04 | 118 | 21 | 3 | M713 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY | 7.15e-04 | 120 | 21 | 3 | M48233 | |
| Pathway | REACTOME_EGR2_AND_SOX10_MEDIATED_INITIATION_OF_SCHWANN_CELL_MYELINATION | 8.38e-04 | 29 | 21 | 2 | M29808 | |
| Pathway | BIOCARTA_TFF_PATHWAY | 8.38e-04 | 29 | 21 | 2 | MM1522 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING | 8.38e-04 | 29 | 21 | 2 | M27756 | |
| Pathway | WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS | 8.38e-04 | 29 | 21 | 2 | M39516 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 8.97e-04 | 30 | 21 | 2 | M27772 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 9.04e-04 | 300 | 21 | 4 | M610 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 9.26e-04 | 302 | 21 | 4 | M39719 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 9.58e-04 | 31 | 21 | 2 | MM1343 | |
| Pathway | WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4 | 1.09e-03 | 33 | 21 | 2 | M39455 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 1.09e-03 | 33 | 21 | 2 | M39503 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 1.09e-03 | 33 | 21 | 2 | M6220 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.12e-03 | 140 | 21 | 3 | M587 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 1.23e-03 | 326 | 21 | 4 | MM15917 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 1.31e-03 | 575 | 21 | 5 | M29853 | |
| Pathway | REACTOME_EARLY_SARS_COV_2_INFECTION_EVENTS | 1.36e-03 | 37 | 21 | 2 | M45028 | |
| Pathway | WP_PI3KAKT_SIGNALING | 1.42e-03 | 339 | 21 | 4 | M39736 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS | 1.44e-03 | 38 | 21 | 2 | M27757 | |
| Pathway | REACTOME_KERATINIZATION | 1.44e-03 | 153 | 21 | 3 | MM15343 | |
| Pathway | WP_BREAST_CANCER_PATHWAY | 1.47e-03 | 154 | 21 | 3 | M39739 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 1.52e-03 | 39 | 21 | 2 | MM14604 | |
| Pathway | WP_BLADDER_CANCER | 1.59e-03 | 40 | 21 | 2 | M39523 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 1.67e-03 | 41 | 21 | 2 | M27778 | |
| Pathway | KEGG_BLADDER_CANCER | 1.76e-03 | 42 | 21 | 2 | M19096 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2 | 1.93e-03 | 44 | 21 | 2 | MM14520 | |
| Pathway | WP_ERBB_SIGNALING_PATHWAY | 2.10e-03 | 46 | 21 | 2 | MM15950 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 2.19e-03 | 47 | 21 | 2 | M29777 | |
| Pathway | REACTOME_SIGNALING_BY_PTK6 | 2.29e-03 | 48 | 21 | 2 | MM15479 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2 | 2.48e-03 | 50 | 21 | 2 | M553 | |
| Pathway | KEGG_ENDOMETRIAL_CANCER | 2.68e-03 | 52 | 21 | 2 | M19877 | |
| Pathway | REACTOME_SIGNALING_BY_PTK6 | 2.89e-03 | 54 | 21 | 2 | M29742 | |
| Pathway | KEGG_NON_SMALL_CELL_LUNG_CANCER | 2.89e-03 | 54 | 21 | 2 | M19818 | |
| Pathway | WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM | 3.55e-03 | 60 | 21 | 2 | M40048 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | 3.64e-03 | 439 | 21 | 4 | M42563 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE | 3.79e-03 | 62 | 21 | 2 | MM14686 | |
| Pathway | WP_TAR_SYNDROME | 3.91e-03 | 63 | 21 | 2 | M48082 | |
| Pathway | WP_ENDOMETRIAL_CANCER | 3.91e-03 | 63 | 21 | 2 | M39623 | |
| Pathway | WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS | 4.28e-03 | 66 | 21 | 2 | M39642 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 4.28e-03 | 66 | 21 | 2 | M18 | |
| Pathway | WP_RAC1PAK1P38MMP2_PATHWAY | 4.54e-03 | 68 | 21 | 2 | M39456 | |
| Pathway | KEGG_PANCREATIC_CANCER | 4.80e-03 | 70 | 21 | 2 | M9726 | |
| Pathway | KEGG_MELANOMA | 4.94e-03 | 71 | 21 | 2 | M15798 | |
| Pathway | WP_NONSMALL_CELL_LUNG_CANCER | 5.07e-03 | 72 | 21 | 2 | M39738 | |
| Pathway | KEGG_ADHERENS_JUNCTION | 5.21e-03 | 73 | 21 | 2 | M638 | |
| Pathway | WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA | 5.35e-03 | 74 | 21 | 2 | M39857 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE | 5.49e-03 | 75 | 21 | 2 | M27032 | |
| Pathway | REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS | 5.92e-03 | 252 | 21 | 3 | MM15585 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 6.08e-03 | 79 | 21 | 2 | M27643 | |
| Pathway | WP_CANCER_PATHWAYS | 6.08e-03 | 507 | 21 | 4 | M48302 | |
| Pubmed | Schwann cell myelination requires integration of laminin activities. | 2.66e-09 | 21 | 30 | 4 | 22767514 | |
| Pubmed | 1.05e-08 | 29 | 30 | 4 | 22613833 | ||
| Pubmed | 2.09e-07 | 14 | 30 | 3 | 18559345 | ||
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 2.62e-07 | 15 | 30 | 3 | 15895400 | |
| Pubmed | 2.76e-07 | 64 | 30 | 4 | 22261194 | ||
| Pubmed | 3.22e-07 | 16 | 30 | 3 | 15028290 | ||
| Pubmed | 3.92e-07 | 175 | 30 | 5 | 28071719 | ||
| Pubmed | 4.68e-07 | 18 | 30 | 3 | 14730302 | ||
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 6.46e-07 | 79 | 30 | 4 | 18757743 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 25349977 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 23871709 | ||
| Pubmed | HER1 R497K and HER2 I655V polymorphisms are linked to development of breast cancer. | 7.19e-07 | 2 | 30 | 2 | 23594562 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 1706616 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 19946741 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 38416376 | ||
| Pubmed | Evolutionary analysis of the ErbB receptor and ligand families. | 7.19e-07 | 2 | 30 | 2 | 10824084 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 20371674 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 15335267 | ||
| Pubmed | Significance of epidermal growth factor receptor expression in breast cancer. | 7.19e-07 | 2 | 30 | 2 | 21104342 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 25589492 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 15143334 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 24664246 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 18199554 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 19294416 | ||
| Pubmed | Expression of erbB-1 and erbB-2 genes in normal and pathological human endometrium. | 7.19e-07 | 2 | 30 | 2 | 17549377 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 23955257 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 27502168 | ||
| Pubmed | Frequent genetic alterations in EGFR- and HER2-driven pathways in breast cancer brain metastases. | 7.19e-07 | 2 | 30 | 2 | 23665199 | |
| Pubmed | Epidermal growth factor receptor activity is necessary for mouse basal cell proliferation. | 7.19e-07 | 2 | 30 | 2 | 25217659 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 19777609 | ||
| Pubmed | Differential cytoskeletal association of ErbB1 and ErbB2 during keratinocyte differentiation. | 7.19e-07 | 2 | 30 | 2 | 12135609 | |
| Pubmed | Dual inhibition of ErbB1 and ErbB2 in cancer by recombinant human prolidase mutant hPEPD-G278D. | 7.19e-07 | 2 | 30 | 2 | 27286447 | |
| Pubmed | Increased concentrations of growth factors and activation of the EGFR system in breast cancer. | 7.19e-07 | 2 | 30 | 2 | 23089711 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 33260837 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 22451678 | ||
| Pubmed | The immune microenvironment in EGFR- and ERBB2-mutated lung adenocarcinoma. | 7.19e-07 | 2 | 30 | 2 | 34487971 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 18946768 | ||
| Pubmed | Dissecting the molecular recognition of dual lapatinib derivatives for EGFR/HER2. | 7.19e-07 | 2 | 30 | 2 | 31828486 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 27273260 | ||
| Pubmed | Association of EGFR and HER2 polymorphisms with risk and clinical features of thyroid cancer. | 7.19e-07 | 2 | 30 | 2 | 19860576 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 19318561 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 12354693 | ||
| Pubmed | Fluorescence-Raman dual modal endoscopic system for multiplexed molecular diagnostics. | 7.19e-07 | 2 | 30 | 2 | 25820115 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 26686087 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 23220854 | ||
| Pubmed | Amplification and expression of EGFR and ERBB2 in Wilms tumor. | 7.19e-07 | 2 | 30 | 2 | 19781441 | |
| Pubmed | Cardiac ErbB-1/ErbB-2 mutant expression in young adult mice leads to cardiac dysfunction. | 7.19e-07 | 2 | 30 | 2 | 18599591 | |
| Pubmed | Therapeutic potential of the dual EGFR/HER2 inhibitor AZD8931 in circumventing endocrine resistance. | 7.19e-07 | 2 | 30 | 2 | 24554387 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 17622245 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 11500850 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 20156584 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 38443188 | ||
| Pubmed | Differential spatial expression and activation pattern of EGFR and HER2 in human breast cancer. | 7.19e-07 | 2 | 30 | 2 | 17611648 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 15211117 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 26437915 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 22891338 | ||
| Pubmed | Expression of epidermal growth factor receptor and HER-2 in pediatric embryonal brain tumors. | 7.19e-07 | 2 | 30 | 2 | 20962551 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 29329808 | ||
| Pubmed | Role of epidermal growth factor and ErbB2 receptors in 3T3-L1 adipogenesis. | 7.19e-07 | 2 | 30 | 2 | 17372305 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 28859123 | ||
| Pubmed | Trastuzumab plus chemotherapy in gastric cancer overexpressing HER-2 and EGFR: a case report. | 7.19e-07 | 2 | 30 | 2 | 21346384 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 24530706 | ||
| Pubmed | Molecular dynamics simulations of asymmetric heterodimers of HER1/HER2 complexes. | 7.19e-07 | 2 | 30 | 2 | 29280017 | |
| Pubmed | A novel proteotoxic combination therapy for EGFR+ and HER2+ cancers. | 7.19e-07 | 2 | 30 | 2 | 30718919 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 23361279 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 32022567 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 21480528 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 21087480 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 39205824 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 25375038 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 19287975 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 21911055 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 26906551 | ||
| Pubmed | Cross-reactivity of EGFR mutation-specific immunohistochemistry assay in HER2-positive tumors. | 7.19e-07 | 2 | 30 | 2 | 25390349 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 16489645 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 12586780 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 30296252 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 30610926 | ||
| Pubmed | Multiple ErbB-2/Neu Phosphorylation Sites Mediate Transformation through Distinct Effector Proteins. | 7.19e-07 | 2 | 30 | 2 | 11500516 | |
| Pubmed | EGFR negates the proliferative effect of oncogenic HER2 in MDA-MB-231 cells. | 7.19e-07 | 2 | 30 | 2 | 25935365 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 19650109 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 20038314 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 27775011 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 20459769 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 19093231 | ||
| Pubmed | Circular HER2 RNA positive triple negative breast cancer is sensitive to Pertuzumab. | 7.19e-07 | 2 | 30 | 2 | 32917240 | |
| Pubmed | EGFR and erbB2 in malignant peripheral nerve sheath tumors and implications for targeted therapy. | 7.19e-07 | 2 | 30 | 2 | 18650488 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 18182111 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 11526509 | ||
| Pubmed | A role of Rab7 in stabilizing EGFR-Her2 and in sustaining Akt survival signal. | 7.19e-07 | 2 | 30 | 2 | 21928319 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 17626639 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 26330166 | ||
| Pubmed | EGFR and HER2 signals play a salvage role in MEK1-mutated gastric cancer after MEK inhibition. | 7.19e-07 | 2 | 30 | 2 | 26081723 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 15233293 | ||
| Pubmed | Critical roles for EGFR and EGFR-HER2 clusters in EGF binding of SW620 human carcinoma cells. | 7.19e-07 | 2 | 30 | 2 | 35612280 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 26114632 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 19855437 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 38040921 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 28388586 | ||
| Pubmed | EGFR and erbB2 mutation status in Japanese lung cancer patients. | 7.19e-07 | 2 | 30 | 2 | 16003726 | |
| Interaction | SPATA3 interactions | 1.48e-10 | 24 | 28 | 5 | int:SPATA3 | |
| Interaction | LCE3D interactions | 5.00e-08 | 73 | 28 | 5 | int:LCE3D | |
| Interaction | LCE1A interactions | 1.02e-07 | 84 | 28 | 5 | int:LCE1A | |
| Interaction | HOXA1 interactions | 4.35e-07 | 356 | 28 | 7 | int:HOXA1 | |
| Interaction | C17orf50 interactions | 5.24e-07 | 12 | 28 | 3 | int:C17orf50 | |
| Interaction | CRCT1 interactions | 2.02e-06 | 66 | 28 | 4 | int:CRCT1 | |
| Interaction | ZNF138 interactions | 2.29e-06 | 19 | 28 | 3 | int:ZNF138 | |
| Interaction | NKD1 interactions | 3.14e-06 | 21 | 28 | 3 | int:NKD1 | |
| Interaction | KRTAP4-5 interactions | 3.57e-06 | 76 | 28 | 4 | int:KRTAP4-5 | |
| Interaction | MOBP interactions | 4.18e-06 | 23 | 28 | 3 | int:MOBP | |
| Interaction | SDF2L1 interactions | 4.45e-06 | 322 | 28 | 6 | int:SDF2L1 | |
| Interaction | ZNF319 interactions | 6.87e-06 | 27 | 28 | 3 | int:ZNF319 | |
| Interaction | LCE5A interactions | 7.01e-06 | 90 | 28 | 4 | int:LCE5A | |
| Interaction | KRTAP5-6 interactions | 8.34e-06 | 94 | 28 | 4 | int:KRTAP5-6 | |
| Interaction | DEFB112 interactions | 1.11e-05 | 4 | 28 | 2 | int:DEFB112 | |
| Interaction | PDGFA interactions | 1.16e-05 | 32 | 28 | 3 | int:PDGFA | |
| Interaction | PRELP interactions | 1.16e-05 | 32 | 28 | 3 | int:PRELP | |
| Interaction | FBXO2 interactions | 1.79e-05 | 411 | 28 | 6 | int:FBXO2 | |
| Interaction | VWC2L interactions | 2.29e-05 | 40 | 28 | 3 | int:VWC2L | |
| Interaction | CCN2 interactions | 2.29e-05 | 40 | 28 | 3 | int:CCN2 | |
| Interaction | ZNF440 interactions | 2.29e-05 | 40 | 28 | 3 | int:ZNF440 | |
| Interaction | CACNA1A interactions | 2.42e-05 | 123 | 28 | 4 | int:CACNA1A | |
| Interaction | PSG8 interactions | 2.47e-05 | 41 | 28 | 3 | int:PSG8 | |
| Interaction | ZNF264 interactions | 2.47e-05 | 41 | 28 | 3 | int:ZNF264 | |
| Interaction | IL5RA interactions | 2.49e-05 | 124 | 28 | 4 | int:IL5RA | |
| Interaction | ITGB4 interactions | 2.57e-05 | 125 | 28 | 4 | int:ITGB4 | |
| Interaction | KRTAP4-2 interactions | 3.19e-05 | 132 | 28 | 4 | int:KRTAP4-2 | |
| Interaction | LCE3B interactions | 3.50e-05 | 46 | 28 | 3 | int:LCE3B | |
| Interaction | GFI1B interactions | 3.58e-05 | 136 | 28 | 4 | int:GFI1B | |
| Interaction | AVPI1 interactions | 3.98e-05 | 48 | 28 | 3 | int:AVPI1 | |
| Interaction | C22orf39 interactions | 4.24e-05 | 49 | 28 | 3 | int:C22orf39 | |
| Interaction | KRTAP10-1 interactions | 5.67e-05 | 153 | 28 | 4 | int:KRTAP10-1 | |
| Interaction | FBXO34 interactions | 6.00e-05 | 55 | 28 | 3 | int:FBXO34 | |
| Interaction | MUC4 interactions | 6.66e-05 | 9 | 28 | 2 | int:MUC4 | |
| Interaction | TYRO3 interactions | 6.75e-05 | 160 | 28 | 4 | int:TYRO3 | |
| Interaction | KRTAP10-5 interactions | 6.75e-05 | 160 | 28 | 4 | int:KRTAP10-5 | |
| Interaction | WDR25 interactions | 7.04e-05 | 58 | 28 | 3 | int:WDR25 | |
| Interaction | LYPD1 interactions | 7.04e-05 | 58 | 28 | 3 | int:LYPD1 | |
| Interaction | LCE3E interactions | 7.79e-05 | 60 | 28 | 3 | int:LCE3E | |
| Interaction | COL9A3 interactions | 8.32e-05 | 10 | 28 | 2 | int:COL9A3 | |
| Interaction | KRTAP5-2 interactions | 8.60e-05 | 62 | 28 | 3 | int:KRTAP5-2 | |
| Interaction | KRTAP5-4 interactions | 9.02e-05 | 63 | 28 | 3 | int:KRTAP5-4 | |
| Interaction | KRTAP10-11 interactions | 9.45e-05 | 64 | 28 | 3 | int:KRTAP10-11 | |
| Interaction | NPDC1 interactions | 9.90e-05 | 65 | 28 | 3 | int:NPDC1 | |
| Interaction | PTPRK interactions | 9.99e-05 | 177 | 28 | 4 | int:PTPRK | |
| Interaction | PTPRT interactions | 1.02e-04 | 11 | 28 | 2 | int:PTPRT | |
| Interaction | POM121L8P interactions | 1.02e-04 | 11 | 28 | 2 | int:POM121L8P | |
| Interaction | KRTAP5-11 interactions | 1.04e-04 | 66 | 28 | 3 | int:KRTAP5-11 | |
| Interaction | KRTAP5-3 interactions | 1.04e-04 | 66 | 28 | 3 | int:KRTAP5-3 | |
| Interaction | LCE3C interactions | 1.08e-04 | 67 | 28 | 3 | int:LCE3C | |
| Interaction | NR1D2 interactions | 1.08e-04 | 67 | 28 | 3 | int:NR1D2 | |
| Interaction | LCE1E interactions | 1.13e-04 | 68 | 28 | 3 | int:LCE1E | |
| Interaction | NR4A3 interactions | 1.18e-04 | 69 | 28 | 3 | int:NR4A3 | |
| Interaction | LCE2A interactions | 1.18e-04 | 69 | 28 | 3 | int:LCE2A | |
| Interaction | LCE1D interactions | 1.24e-04 | 70 | 28 | 3 | int:LCE1D | |
| Interaction | NAXD interactions | 1.29e-04 | 71 | 28 | 3 | int:NAXD | |
| Interaction | ZNF559 interactions | 1.44e-04 | 13 | 28 | 2 | int:ZNF559 | |
| Interaction | LCE2D interactions | 1.46e-04 | 74 | 28 | 3 | int:LCE2D | |
| Interaction | WT1 interactions | 1.58e-04 | 76 | 28 | 3 | int:WT1 | |
| Interaction | LCE3A interactions | 1.58e-04 | 76 | 28 | 3 | int:LCE3A | |
| Interaction | LCE1C interactions | 1.64e-04 | 77 | 28 | 3 | int:LCE1C | |
| Interaction | PIN1 interactions | 1.66e-04 | 383 | 28 | 5 | int:PIN1 | |
| Interaction | PRR19 interactions | 1.68e-04 | 14 | 28 | 2 | int:PRR19 | |
| Interaction | ROBO4 interactions | 1.68e-04 | 14 | 28 | 2 | int:ROBO4 | |
| Interaction | KRTAP5-9 interactions | 1.69e-04 | 203 | 28 | 4 | int:KRTAP5-9 | |
| Interaction | LCE4A interactions | 1.84e-04 | 80 | 28 | 3 | int:LCE4A | |
| Interaction | KRTAP4-4 interactions | 1.91e-04 | 81 | 28 | 3 | int:KRTAP4-4 | |
| Interaction | LCE2B interactions | 1.91e-04 | 81 | 28 | 3 | int:LCE2B | |
| Interaction | ADAMTSL3 interactions | 1.93e-04 | 15 | 28 | 2 | int:ADAMTSL3 | |
| Interaction | APOL6 interactions | 1.93e-04 | 15 | 28 | 2 | int:APOL6 | |
| Interaction | ZNF625 interactions | 1.93e-04 | 15 | 28 | 2 | int:ZNF625 | |
| Interaction | POU4F2 interactions | 2.05e-04 | 83 | 28 | 3 | int:POU4F2 | |
| Interaction | KRTAP10-8 interactions | 2.05e-04 | 401 | 28 | 5 | int:KRTAP10-8 | |
| Interaction | PTPRH interactions | 2.12e-04 | 84 | 28 | 3 | int:PTPRH | |
| Interaction | LCE1B interactions | 2.20e-04 | 85 | 28 | 3 | int:LCE1B | |
| Interaction | KRTAP4-7 interactions | 2.21e-04 | 16 | 28 | 2 | int:KRTAP4-7 | |
| Interaction | MEGF6 interactions | 2.21e-04 | 16 | 28 | 2 | int:MEGF6 | |
| Interaction | SUSD2 interactions | 2.21e-04 | 16 | 28 | 2 | int:SUSD2 | |
| Interaction | AREG interactions | 2.21e-04 | 16 | 28 | 2 | int:AREG | |
| Interaction | CEND1 interactions | 2.21e-04 | 16 | 28 | 2 | int:CEND1 | |
| Interaction | NID2 interactions | 2.28e-04 | 86 | 28 | 3 | int:NID2 | |
| Interaction | SIRPD interactions | 2.28e-04 | 86 | 28 | 3 | int:SIRPD | |
| Interaction | LCE2C interactions | 2.44e-04 | 88 | 28 | 3 | int:LCE2C | |
| Interaction | KRTAP10-6 interactions | 2.44e-04 | 88 | 28 | 3 | int:KRTAP10-6 | |
| Interaction | CAMK1G interactions | 2.50e-04 | 17 | 28 | 2 | int:CAMK1G | |
| Interaction | RNF8 interactions | 2.57e-04 | 421 | 28 | 5 | int:RNF8 | |
| Interaction | LCE1F interactions | 2.78e-04 | 92 | 28 | 3 | int:LCE1F | |
| Interaction | KRTAP4-11 interactions | 2.78e-04 | 92 | 28 | 3 | int:KRTAP4-11 | |
| Interaction | ZAP70 interactions | 2.78e-04 | 92 | 28 | 3 | int:ZAP70 | |
| Interaction | SHD interactions | 2.81e-04 | 18 | 28 | 2 | int:SHD | |
| Interaction | MPZL2 interactions | 2.81e-04 | 18 | 28 | 2 | int:MPZL2 | |
| Interaction | TNS2 interactions | 2.96e-04 | 235 | 28 | 4 | int:TNS2 | |
| Interaction | ADAMTS1 interactions | 3.05e-04 | 95 | 28 | 3 | int:ADAMTS1 | |
| Interaction | SHFL interactions | 3.24e-04 | 97 | 28 | 3 | int:SHFL | |
| Interaction | KRTAP10-9 interactions | 3.26e-04 | 241 | 28 | 4 | int:KRTAP10-9 | |
| Interaction | GGH interactions | 3.36e-04 | 243 | 28 | 4 | int:GGH | |
| Interaction | ZNF114 interactions | 3.48e-04 | 20 | 28 | 2 | int:ZNF114 | |
| Interaction | KRTAP9-8 interactions | 3.55e-04 | 100 | 28 | 3 | int:KRTAP9-8 | |
| Interaction | DEFA1 interactions | 3.55e-04 | 100 | 28 | 3 | int:DEFA1 | |
| Interaction | FBXO6 interactions | 3.83e-04 | 717 | 28 | 6 | int:FBXO6 | |
| Cytoband | 21q22.3 | 8.13e-05 | 128 | 30 | 3 | 21q22.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr21q22 | 1.89e-03 | 377 | 30 | 3 | chr21q22 | |
| Cytoband | 11p15.5 | 2.72e-03 | 118 | 30 | 2 | 11p15.5 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p36 | 9.80e-03 | 681 | 30 | 3 | chr1p36 | |
| GeneFamily | Keratin associated proteins | 3.58e-06 | 109 | 18 | 4 | 619 | |
| GeneFamily | Erb-b2 receptor tyrosine kinases | 5.61e-06 | 4 | 18 | 2 | 1096 | |
| GeneFamily | Laminin subunits | 6.14e-05 | 12 | 18 | 2 | 626 | |
| Coexpression | NABA_MATRISOME | VWC2L BRINP2 LAMA2 KCP LAMB1 SLIT2 HSPG2 FGF10 FRAS1 MUC5B MEGF6 MEGF8 CCN3 | 8.17e-12 | 1008 | 28 | 13 | MM17056 |
| Coexpression | NABA_MATRISOME | VWC2L BRINP2 LAMA2 KCP LAMB1 SLIT2 HSPG2 FGF10 FRAS1 MUC5B MEGF6 MEGF8 CCN3 | 1.02e-11 | 1026 | 28 | 13 | M5889 |
| Coexpression | NABA_CORE_MATRISOME | 1.12e-08 | 270 | 28 | 7 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 1.27e-08 | 275 | 28 | 7 | M5884 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 4.56e-08 | 191 | 28 | 6 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 5.32e-08 | 196 | 28 | 6 | M3008 | |
| Coexpression | HEVNER_TELENCEPHALON_VASCULAR_ENDOTHELIUM_AND_MENINGEAL_CELLS | 4.92e-07 | 15 | 28 | 3 | MM402 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | 8.73e-06 | 268 | 28 | 5 | M45796 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 1.05e-05 | 40 | 28 | 3 | M5887 | |
| Coexpression | PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN | 1.31e-05 | 43 | 28 | 3 | M12432 | |
| Coexpression | NABA_SECRETED_FACTORS | 2.67e-05 | 338 | 28 | 5 | MM17064 | |
| Coexpression | YAMAZAKI_TCEB3_TARGETS_UP | 2.82e-05 | 166 | 28 | 4 | M1542 | |
| Coexpression | NABA_SECRETED_FACTORS | 2.86e-05 | 343 | 28 | 5 | M5883 | |
| Coexpression | TCGA_GLIOBLASTOMA_MUTATED | 3.07e-05 | 8 | 28 | 2 | M19387 | |
| Coexpression | YAMAZAKI_TCEB3_TARGETS_UP | 3.79e-05 | 179 | 28 | 4 | MM660 | |
| Coexpression | PEREZ_TP53_AND_TP63_TARGETS | 6.67e-05 | 207 | 28 | 4 | M14566 | |
| Coexpression | FRASOR_RESPONSE_TO_ESTRADIOL_DN | 7.87e-05 | 78 | 28 | 3 | M3002 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 1.08e-04 | 738 | 28 | 6 | MM17058 | |
| Coexpression | BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER | 1.15e-04 | 15 | 28 | 2 | M18219 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 1.19e-04 | 751 | 28 | 6 | M5885 | |
| Coexpression | CHIBA_RESPONSE_TO_TSA_DN | 2.28e-04 | 21 | 28 | 2 | M12459 | |
| Coexpression | PLASARI_NFIC_TARGETS_BASAL_DN | 2.51e-04 | 22 | 28 | 2 | M2449 | |
| Coexpression | PLASARI_NFIC_TARGETS_BASAL_DN | 2.75e-04 | 23 | 28 | 2 | MM945 | |
| Coexpression | GSE12839_CTRL_VS_IL12_TREATED_PBMC_DN | 3.33e-04 | 127 | 28 | 3 | M441 | |
| Coexpression | GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TREG_CD4_TCELL_DN | 4.34e-04 | 139 | 28 | 3 | M8948 | |
| Coexpression | THEODOROU_MAMMARY_TUMORIGENESIS | 5.02e-04 | 31 | 28 | 2 | M1291 | |
| Coexpression | PEREZ_TP63_TARGETS | 5.29e-04 | 356 | 28 | 4 | M10761 | |
| Coexpression | DESCARTES_FETAL_LIVER_STELLATE_CELLS | 6.54e-04 | 160 | 28 | 3 | M40233 | |
| Coexpression | VERHAAK_GLIOBLASTOMA_CLASSICAL | 6.66e-04 | 161 | 28 | 3 | M2121 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 7.10e-04 | 385 | 28 | 4 | M39264 | |
| Coexpression | THEODOROU_MAMMARY_TUMORIGENESIS | 7.16e-04 | 37 | 28 | 2 | MM1121 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_PROLIFERATING_SCHWANN_CELL | 7.34e-04 | 1054 | 28 | 6 | M45798 | |
| Coexpression | LAKE_ADULT_KIDNEY_C15_CONNECTING_TUBULE | 7.93e-04 | 171 | 28 | 3 | M39234 | |
| Coexpression | GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN | 8.79e-04 | 41 | 28 | 2 | M6979 | |
| Coexpression | VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP | 8.90e-04 | 178 | 28 | 3 | M17079 | |
| Coexpression | DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN | 9.05e-04 | 179 | 28 | 3 | M8519 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 1.51e-05 | 437 | 27 | 6 | GSM777046_500 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 1.67e-05 | 445 | 27 | 6 | GSM777043_500 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 1.85e-05 | 453 | 27 | 6 | GSM777067_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_200 | 1.52e-04 | 82 | 27 | 3 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_200 | |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | 2.05e-04 | 439 | 27 | 5 | GSM777059_500 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 2.50e-04 | 97 | 27 | 3 | GSM777043_100 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | 3.39e-04 | 768 | 27 | 6 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-09 | 160 | 30 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-09 | 160 | 30 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.95e-09 | 191 | 30 | 6 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 3.04e-09 | 192 | 30 | 6 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 3.24e-09 | 194 | 30 | 6 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 3.34e-09 | 195 | 30 | 6 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.31e-07 | 181 | 30 | 5 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.50e-07 | 186 | 30 | 5 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.58e-07 | 188 | 30 | 5 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.67e-07 | 190 | 30 | 5 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.71e-07 | 191 | 30 | 5 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-07 | 191 | 30 | 5 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.76e-07 | 192 | 30 | 5 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-07 | 192 | 30 | 5 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-07 | 192 | 30 | 5 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 1.80e-07 | 193 | 30 | 5 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 1.80e-07 | 193 | 30 | 5 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 1.85e-07 | 194 | 30 | 5 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.90e-07 | 195 | 30 | 5 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.90e-07 | 195 | 30 | 5 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.99e-07 | 197 | 30 | 5 | 17344464fdcc5ba0c03959696b97c195f11e644c | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal-mesenchymal_stem_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.99e-07 | 197 | 30 | 5 | 3bb92dd8a94e2be3b7fe51c9a21b241215477ac7 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.99e-07 | 197 | 30 | 5 | 5b8d0d7116b20d8e27541e88ec80c9f1f477e384 | |
| ToppCell | Fibroblasts-HLA-DRA_high_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.04e-07 | 198 | 30 | 5 | e8c0fbf306fae13e97caa294d7c99a564bd97130 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.15e-07 | 200 | 30 | 5 | b5b5a32925f225610fe25a021a742d6397162863 | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell|Adult / Lineage, Cell type, age group and donor | 4.65e-06 | 167 | 30 | 4 | d584a8548a5317bd9686b3be8246ae6ed568796b | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 4.88e-06 | 169 | 30 | 4 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | NS-critical-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.88e-06 | 169 | 30 | 4 | aec97583b23112060437b619cb429dc32f29285f | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.23e-06 | 172 | 30 | 4 | e15ab284df6dd241d4481f98864b18c39d757b8c | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-stromal_related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.60e-06 | 175 | 30 | 4 | b8995e7ada85ba959f06264a0295b61e390c4e6c | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-stromal_related-T_reticular|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.60e-06 | 175 | 30 | 4 | 7ae76bd3b4f610b2f98716a4456437cd3696b686 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 5.86e-06 | 177 | 30 | 4 | 3d955ea938a1d2fb1b6d68d4997fd454bd632dfc | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 5.86e-06 | 177 | 30 | 4 | eb0cfe8e9a91910f9979608ed47add48d98ce4dd | |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | 6.12e-06 | 179 | 30 | 4 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.40e-06 | 181 | 30 | 4 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.54e-06 | 182 | 30 | 4 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.68e-06 | 183 | 30 | 4 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.83e-06 | 184 | 30 | 4 | 102b6f621a5b551e622f97b12d787c080b052a72 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.83e-06 | 184 | 30 | 4 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.83e-06 | 184 | 30 | 4 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.98e-06 | 185 | 30 | 4 | bdd2e6cb20294b39a9d856004bf57ba69cf877e2 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.98e-06 | 185 | 30 | 4 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 7.28e-06 | 187 | 30 | 4 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 7.28e-06 | 187 | 30 | 4 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | AT1_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 7.28e-06 | 187 | 30 | 4 | f1dda349335e08dbfc8395d373924037f5ad2fd6 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 7.28e-06 | 187 | 30 | 4 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 7.43e-06 | 188 | 30 | 4 | c90669b51e1902fe7726555290c91c92a911df83 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.43e-06 | 188 | 30 | 4 | de6f4889e0c5f39fbbaefd85526f645c6afa09d5 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.59e-06 | 189 | 30 | 4 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | LV-14._Fibroblast_III|World / Chamber and Cluster_Paper | 7.59e-06 | 189 | 30 | 4 | 3922135d1f6fc768d71ba3b465585fead6ea68a8 | |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | 7.59e-06 | 189 | 30 | 4 | d7ed96add29f219183c802895fbff519b627f635 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.75e-06 | 190 | 30 | 4 | bd0d68dc1b6f388190a6ba8a83b011619abe2bdd | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.75e-06 | 190 | 30 | 4 | e275de94468872e70cf305b3b450823d4c9c5e3f | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.75e-06 | 190 | 30 | 4 | ee2f4a55d2fd18b83e55399b5b5697a15a2d2e70 | |
| ToppCell | ASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.91e-06 | 191 | 30 | 4 | 1726add3f392a061536b7aff72ba84303f4a0b1f | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 7.91e-06 | 191 | 30 | 4 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.91e-06 | 191 | 30 | 4 | cd497abed9e00e4e0becd9dbc036c6e7a60ae791 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.91e-06 | 191 | 30 | 4 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | ASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.91e-06 | 191 | 30 | 4 | e30ae7a12439f8a79820b13f03e822c1223fd0cb | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.08e-06 | 192 | 30 | 4 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.08e-06 | 192 | 30 | 4 | ac1477433704573f95111eee6263b93668d2845e | |
| ToppCell | droplet-Lung-30m-Mesenchymal|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.08e-06 | 192 | 30 | 4 | 5d5bec238b196f0b3e727fd94f078d6ae524cb01 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.08e-06 | 192 | 30 | 4 | 1b228f0929b505de82a39bf64c837887b0e56701 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.08e-06 | 192 | 30 | 4 | 32acd89617934016cd135d2cc797e8e79ae1b37f | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.08e-06 | 192 | 30 | 4 | a2c31390da4962bda9a936470b0b68fa1f5d47d1 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.08e-06 | 192 | 30 | 4 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.08e-06 | 192 | 30 | 4 | 158cc5736f154da1cb3186ffbf186eae10483e48 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.08e-06 | 192 | 30 | 4 | 7b48df661f61ce494bf6f0b9a74b0422e29c24bf | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.08e-06 | 192 | 30 | 4 | eeab1cef7c36ae824381952c5b2c982368c379fd | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.08e-06 | 192 | 30 | 4 | 2d9e2262f1342fe17735f21f733c029d1275e955 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.08e-06 | 192 | 30 | 4 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.08e-06 | 192 | 30 | 4 | f4ff62ac9c53eafbe917706de9af8b2d4bded4d4 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.24e-06 | 193 | 30 | 4 | 9d0b966d13cbce97beb43de6dc77f006c363a181 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.24e-06 | 193 | 30 | 4 | 4c74a3f69b2cbdf139e7e66b44bd86869ac34dc0 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.24e-06 | 193 | 30 | 4 | ff8ceeb3cfd1bef7239df490c19d181091750833 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.24e-06 | 193 | 30 | 4 | d9c20a092b507c43fcf7ccb04073fecd27d1749c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.24e-06 | 193 | 30 | 4 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.24e-06 | 193 | 30 | 4 | fe9720185929ef849edd1b8eb4854306b392e5a2 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 8.24e-06 | 193 | 30 | 4 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 8.41e-06 | 194 | 30 | 4 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.41e-06 | 194 | 30 | 4 | e2db75f4de114631b8bda4e188f84446545538b7 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.41e-06 | 194 | 30 | 4 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.41e-06 | 194 | 30 | 4 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | LV-14._Fibroblast_III|LV / Chamber and Cluster_Paper | 8.41e-06 | 194 | 30 | 4 | 927c26aea0147f7a4b8fb3f192de4de263f1b978 | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 8.41e-06 | 194 | 30 | 4 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.58e-06 | 195 | 30 | 4 | 69a29d03e664b72f32d41876510c62345c3aed31 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.58e-06 | 195 | 30 | 4 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.58e-06 | 195 | 30 | 4 | 1cffae2b08dbfa1c633ce24023e89b66d28b5431 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.58e-06 | 195 | 30 | 4 | f5e91ce20a7ce528dc4c1a968c7bf096bf45c528 | |
| ToppCell | facs-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.58e-06 | 195 | 30 | 4 | c4648c0332c3826776f9ad3f5f803dbac2b4c0c0 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 8.58e-06 | 195 | 30 | 4 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.58e-06 | 195 | 30 | 4 | 9cef6f18664518060af7c192310dddce6d70345a | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.58e-06 | 195 | 30 | 4 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 8.76e-06 | 196 | 30 | 4 | 6730743cf088c419ccc2d28765769fc09d3ba6a7 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.76e-06 | 196 | 30 | 4 | d4676a6b0d9e417795fc9a6bcb1762d3dd656ca9 | |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.76e-06 | 196 | 30 | 4 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 8.76e-06 | 196 | 30 | 4 | 21dab89f3699037138a9c7a0e4dc98739a9fad9c | |
| ToppCell | facs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.76e-06 | 196 | 30 | 4 | 787c6cd92035e0b1108c2c086c42a229016e476b | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.94e-06 | 197 | 30 | 4 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | COPD-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 8.94e-06 | 197 | 30 | 4 | d51f484b4e01ac64233950d0b97fa88825ea1dbb | |
| Drug | N-(2-(4-((3-chloro-4-(3-(trifluoromethyl)phenoxy)phenyl)amino)-5H-pyrrolo(3,2-d)pyrimidin-5-yl)ethyl)-3-hydroxy-3-methylbutanamide | 1.68e-06 | 2 | 30 | 2 | ctd:C570404 | |
| Drug | Lapatinib | 1.68e-06 | 2 | 30 | 2 | DB01259 | |
| Drug | 2-acetamidoethanethiol | 5.03e-06 | 3 | 30 | 2 | ctd:C023704 | |
| Drug | 4557 W | 5.03e-06 | 3 | 30 | 2 | ctd:C433938 | |
| Drug | 4-aminopyrimidine-5-carbaldehyde | 5.03e-06 | 3 | 30 | 2 | CID011228787 | |
| Drug | pyrido[3,4-d]pyrimidine | 5.03e-06 | 3 | 30 | 2 | CID014758064 | |
| Drug | 5-iodonicotinic acid | 5.03e-06 | 3 | 30 | 2 | CID000151950 | |
| Drug | EGFR/ErbB2 inhibitor | 1.01e-05 | 4 | 30 | 2 | CID009843206 | |
| Drug | tyrphostin AG825 | 1.01e-05 | 4 | 30 | 2 | CID000002062 | |
| Drug | TAK-165 | 1.67e-05 | 5 | 30 | 2 | CID006444692 | |
| Drug | B-31 | 2.51e-05 | 6 | 30 | 2 | CID000122475 | |
| Drug | ZD-6 | 2.51e-05 | 6 | 30 | 2 | CID010062753 | |
| Drug | AC1L1JJ0 | 3.51e-05 | 7 | 30 | 2 | CID000005061 | |
| Drug | deazapurine | 3.51e-05 | 7 | 30 | 2 | CID000261591 | |
| Drug | PKI 166 | 3.51e-05 | 7 | 30 | 2 | ctd:C410026 | |
| Drug | secoisolariciresinol diglucoside | 3.51e-05 | 7 | 30 | 2 | ctd:C090142 | |
| Drug | Folfox protocol | 4.68e-05 | 8 | 30 | 2 | ctd:C410216 | |
| Drug | kalinin | 5.17e-05 | 55 | 30 | 3 | CID000032518 | |
| Drug | vinyl sulfonamide | 6.01e-05 | 9 | 30 | 2 | CID000520075 | |
| Drug | but-2-enamide | 6.01e-05 | 9 | 30 | 2 | CID000031877 | |
| Drug | 6-(methylamino)pyrido(3,4-d)pyrimidine | 7.50e-05 | 10 | 30 | 2 | ctd:C107875 | |
| Drug | sulfo-MBS | 9.16e-05 | 11 | 30 | 2 | CID000124851 | |
| Drug | GW2974 | 9.16e-05 | 11 | 30 | 2 | CID006603857 | |
| Drug | AC1L1G72 | 9.16e-05 | 11 | 30 | 2 | CID000003553 | |
| Drug | BE-23372M | 9.16e-05 | 11 | 30 | 2 | CID005311105 | |
| Drug | compound 56 | 9.16e-05 | 11 | 30 | 2 | CID000002857 | |
| Drug | N-methyl-3-(1-(4-(piperazin-1-yl)phenyl)-5-(4'-(trifluoromethyl)-(1,1'-biphenyl)-4-yl)-1H-pyrazol-3-yl)propanamide | 1.10e-04 | 12 | 30 | 2 | ctd:C562238 | |
| Drug | AC1L28C4 | 1.10e-04 | 12 | 30 | 2 | CID000042675 | |
| Drug | Canertinib | 1.10e-04 | 12 | 30 | 2 | ctd:C420268 | |
| Drug | Norgestrel-(-)-D [797-63-7]; Up 200; 12.8uM; PC3; HT_HG-U133A | 1.15e-04 | 193 | 30 | 4 | 3708_UP | |
| Drug | Dropropizine (R,S) [17692-31-8]; Up 200; 17uM; MCF7; HT_HG-U133A | 1.18e-04 | 194 | 30 | 4 | 5531_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; PC3; HG-U133A | 1.18e-04 | 194 | 30 | 4 | 433_DN | |
| Drug | Benperidol [2062-84-2]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 1.20e-04 | 195 | 30 | 4 | 4781_UP | |
| Drug | Bicuculline (+) [485-49-4]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 1.25e-04 | 197 | 30 | 4 | 2796_DN | |
| Drug | CMF regimen | 1.30e-04 | 13 | 30 | 2 | ctd:C034456 | |
| Drug | Trastuzumab | 1.30e-04 | 13 | 30 | 2 | DB00072 | |
| Drug | Furazolidone [67-45-8]; Up 200; 17.8uM; MCF7; HT_HG-U133A | 1.30e-04 | 199 | 30 | 4 | 4178_UP | |
| Drug | A0395 | 1.31e-04 | 75 | 30 | 3 | CID009906466 | |
| Drug | FK-506; Up 200; 1uM; MCF7; HG-U133A | 1.32e-04 | 200 | 30 | 4 | 378_UP | |
| Drug | Carbarsone [121-59-5]; Down 200; 15.4uM; PC3; HT_HG-U133A | 1.32e-04 | 200 | 30 | 4 | 3991_DN | |
| Drug | 2-amino-5-methylpyridine | 1.41e-04 | 77 | 30 | 3 | CID000015348 | |
| Drug | Tapi | 1.58e-04 | 80 | 30 | 3 | CID003035404 | |
| Drug | Antineoplastic Agents | 1.74e-04 | 15 | 30 | 2 | ctd:D000970 | |
| Drug | NVP-TAE684 | 1.74e-04 | 15 | 30 | 2 | ctd:C516714 | |
| Drug | 2-[(1R,2R,3S,4R,5R,6S)-2-[(2R,5S)-3-[(3S,4S,5R,6S)-4,5-dihydroxy-3-(methylamino)-6-methylol-tetrahydropyran-2-yl]-4-formyl-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine | 1.77e-04 | 83 | 30 | 3 | CID011968896 | |
| Drug | AC1L1G2K | 1.83e-04 | 84 | 30 | 3 | CID000003498 | |
| Drug | NSC 714187 | 1.90e-04 | 85 | 30 | 3 | CID005288693 | |
| Drug | LMWH | 1.95e-04 | 663 | 30 | 6 | CID000000772 | |
| Drug | lapatinib | 1.96e-04 | 86 | 30 | 3 | CID000208908 | |
| Drug | 4-anilinoquinazoline | 1.99e-04 | 16 | 30 | 2 | CID000324081 | |
| Drug | sulfate | 2.00e-04 | 1292 | 30 | 8 | CID000001117 | |
| Drug | MEN 11420 | 2.25e-04 | 17 | 30 | 2 | CID003086682 | |
| Drug | CL-387,785 | 3.14e-04 | 20 | 30 | 2 | CID000002776 | |
| Drug | NSC740137 | 3.34e-04 | 103 | 30 | 3 | CID000003817 | |
| Drug | capecitabine | 3.44e-04 | 104 | 30 | 3 | CID000060953 | |
| Drug | 6)-gingerol | 3.47e-04 | 21 | 30 | 2 | CID000090942 | |
| Drug | phenadoxone | 3.81e-04 | 22 | 30 | 2 | CID000010089 | |
| Drug | bosutinib | 3.81e-04 | 22 | 30 | 2 | ctd:C471992 | |
| Drug | Methylnitronitrosoguanidine | 3.87e-04 | 265 | 30 | 4 | ctd:D008769 | |
| Drug | AC1L1C2F | 4.05e-04 | 110 | 30 | 3 | CID000001711 | |
| Drug | AC1L1CT9 | 4.17e-04 | 23 | 30 | 2 | CID000002054 | |
| Drug | PHA665752 | 4.17e-04 | 23 | 30 | 2 | CID010461815 | |
| Drug | hydroxytamoxifen | 4.85e-04 | 117 | 30 | 3 | ctd:C475919 | |
| Drug | Quinazolines | 4.94e-04 | 25 | 30 | 2 | ctd:D011799 | |
| Drug | genistein | 5.06e-04 | 1117 | 30 | 7 | CID005280961 | |
| Drug | Reserpine | 5.10e-04 | 119 | 30 | 3 | ctd:D012110 | |
| Drug | 94 PU | 5.35e-04 | 26 | 30 | 2 | CID000023940 | |
| Drug | BIBX1382BS | 5.35e-04 | 26 | 30 | 2 | CID006918508 | |
| Drug | NVP & EFV | 5.35e-04 | 121 | 30 | 3 | CID000492400 | |
| Drug | Arsenates | 5.48e-04 | 122 | 30 | 3 | ctd:D001149 | |
| Drug | Caspofungin [inn] | 5.77e-04 | 27 | 30 | 2 | CID000151068 | |
| Drug | benzylidenemalononitrile | 5.77e-04 | 27 | 30 | 2 | CID000017608 | |
| Drug | saracatinib | 5.77e-04 | 27 | 30 | 2 | CID010302451 | |
| Disease | Cetuximab response | 8.05e-06 | 5 | 27 | 2 | cv:CN077967 | |
| Disease | Panitumumab response | 8.05e-06 | 5 | 27 | 2 | cv:CN077999 | |
| Disease | Head and Neck Carcinoma | 3.61e-05 | 10 | 27 | 2 | C3887461 | |
| Disease | gallbladder neoplasm | 4.41e-05 | 11 | 27 | 2 | C0016978 | |
| Disease | Malignant neoplasm of gallbladder | 4.41e-05 | 11 | 27 | 2 | C0153452 | |
| Disease | Papilloma | 5.29e-05 | 12 | 27 | 2 | C0030354 | |
| Disease | Papillomatosis | 5.29e-05 | 12 | 27 | 2 | C0205875 | |
| Disease | Papilloma, Squamous Cell | 5.29e-05 | 12 | 27 | 2 | C0205874 | |
| Disease | Lung cancer | 7.29e-05 | 14 | 27 | 2 | cv:C0242379 | |
| Disease | LUNG CANCER | 7.29e-05 | 14 | 27 | 2 | 211980 | |
| Disease | median neuropathy (biomarker_via_orthology) | 7.29e-05 | 14 | 27 | 2 | DOID:571 (biomarker_via_orthology) | |
| Disease | Neoplasm of lung | 7.29e-05 | 14 | 27 | 2 | cv:C0024121 | |
| Disease | urinary bladder cancer (is_marker_for) | 1.27e-04 | 107 | 27 | 3 | DOID:11054 (is_marker_for) | |
| Disease | laryngeal squamous cell carcinoma (is_marker_for) | 1.37e-04 | 19 | 27 | 2 | DOID:2876 (is_marker_for) | |
| Disease | Polydactyly | 1.66e-04 | 117 | 27 | 3 | C0152427 | |
| Disease | hypertension | 1.67e-04 | 307 | 27 | 4 | EFO_0000537 | |
| Disease | Carcinoma of lung | 2.02e-04 | 23 | 27 | 2 | C0684249 | |
| Disease | Intrahepatic Cholangiocarcinoma | 2.20e-04 | 24 | 27 | 2 | C0345905 | |
| Disease | stomach carcinoma (is_marker_for) | 2.20e-04 | 24 | 27 | 2 | DOID:5517 (is_marker_for) | |
| Disease | Extrahepatic Cholangiocarcinoma | 2.20e-04 | 24 | 27 | 2 | C3805278 | |
| Disease | Cholangiocarcinoma | 2.59e-04 | 26 | 27 | 2 | C0206698 | |
| Disease | Mammary Carcinoma, Animal | 2.93e-04 | 142 | 27 | 3 | C1257925 | |
| Disease | Animal Mammary Neoplasms | 2.93e-04 | 142 | 27 | 3 | C0024667 | |
| Disease | Mammary Neoplasms, Experimental | 3.79e-04 | 155 | 27 | 3 | C0024668 | |
| Disease | intestinal cancer (implicated_via_orthology) | 3.93e-04 | 32 | 27 | 2 | DOID:10155 (implicated_via_orthology) | |
| Disease | Head and Neck Neoplasms | 4.18e-04 | 33 | 27 | 2 | C0018671 | |
| Disease | Endometrioma | 4.24e-04 | 161 | 27 | 3 | C0269102 | |
| Disease | Endometriosis | 4.24e-04 | 161 | 27 | 3 | C0014175 | |
| Disease | retinal detachment, retinal break | 4.71e-04 | 35 | 27 | 2 | EFO_0005773, EFO_0010698 | |
| Disease | visceral heterotaxy (implicated_via_orthology) | 5.26e-04 | 37 | 27 | 2 | DOID:0050545 (implicated_via_orthology) | |
| Disease | Neoplasm Recurrence, Local | 5.85e-04 | 39 | 27 | 2 | C0027643 | |
| Disease | Congenital small ears | 6.47e-04 | 41 | 27 | 2 | C0152423 | |
| Disease | Malignant Head and Neck Neoplasm | 7.45e-04 | 44 | 27 | 2 | C0278996 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 9.23e-04 | 49 | 27 | 2 | DOID:3910 (is_implicated_in) | |
| Disease | attention deficit hyperactivity disorder, bipolar disorder, autism spectrum disorder, schizophrenia, major depressive disorder | 1.00e-03 | 51 | 27 | 2 | EFO_0003756, EFO_0003888, MONDO_0002009, MONDO_0004985, MONDO_0005090 | |
| Disease | Small cell carcinoma of lung | 1.12e-03 | 54 | 27 | 2 | C0149925 | |
| Disease | pre-eclampsia (is_marker_for) | 1.29e-03 | 58 | 27 | 2 | DOID:10591 (is_marker_for) | |
| Disease | transitional cell carcinoma (is_marker_for) | 1.52e-03 | 63 | 27 | 2 | DOID:2671 (is_marker_for) | |
| Disease | oral squamous cell carcinoma (is_marker_for) | 1.52e-03 | 63 | 27 | 2 | DOID:0050866 (is_marker_for) | |
| Disease | carcinoma (implicated_via_orthology) | 1.57e-03 | 64 | 27 | 2 | DOID:305 (implicated_via_orthology) | |
| Disease | Parkinson's disease (is_marker_for) | 1.72e-03 | 67 | 27 | 2 | DOID:14330 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GACQPCPINCTHSCV | 621 | P04626 | |
| CFSTHCVSGCVCPPG | 826 | Q9HC84 | |
| CSGCNCNGHASSCDP | 761 | P98160 | |
| CQPCNTHCGSCDSQA | 906 | Q86XX4 | |
| HKCENPCHAGSCQPC | 321 | Q6ZNB6 | |
| ACQFRCQCHGAPCDP | 186 | Q5VY43 | |
| CQCHGAPCDPQTGAC | 191 | Q5VY43 | |
| CQSHGQCQPPGVCAC | 146 | Q7Z7M0 | |
| AGCCVQCSHGRCPTA | 841 | O75164 | |
| PCGHTVCCESCAAQL | 401 | Q8WY64 | |
| CDPCNCNAAHSFGPS | 1081 | P07942 | |
| CAASPPNCCHPSCCQ | 16 | G5E9R7 | |
| PQCCHSVCFQPTCCH | 91 | G5E9R7 | |
| TCVPCQCNGHSSLCD | 1416 | P24043 | |
| TCEPGPFCHVNLCAC | 96 | P39877 | |
| KSPSDCCHNQCAAGC | 226 | P00533 | |
| FCGVCSDGRCCTPHN | 291 | P48745 | |
| ILNPHAASCTCAACC | 271 | O75398 | |
| CAPCHASCATCQGPA | 641 | P09958 | |
| ACPESCCEPHCCALS | 21 | P60331 | |
| QSSCHPACCTSSPCQ | 166 | P60331 | |
| CQPACCTSSPCQHAC | 256 | P60371 | |
| CQHACCVPVCSGAST | 266 | P60371 | |
| PASSCQPSCCHPASC | 231 | P60410 | |
| QPSCCHPASCLSFLC | 236 | P60410 | |
| LCANVECPPAHTCPC | 6 | Q8N1N5 | |
| HTCPCGVPACSCAHV | 16 | Q8N1N5 | |
| ECSPAHTCRCGVPAC | 196 | Q8N1N5 | |
| SAFPHLPGCCCCCFL | 11 | O15520 | |
| CCASAHCPCCGQGAP | 276 | Q5T953 | |
| NPACHPATGTCSCAA | 1181 | O75095 | |
| PCSCHPTCSGLGTCC | 41 | Q9UGT4 | |
| DPCSHCRCANGSVQC | 331 | Q6ZWJ8 | |
| AGPHSCSCATCPCSS | 106 | Q8NHX4 | |
| CAHCAPDNSTRCGSC | 466 | Q9C0B6 | |
| CPPNASCVNNTHCTC | 31 | Q9BY15 | |
| PSCSVLHCPAACTCS | 266 | O94813 | |
| HSNCPCVCALDGPVC | 71 | B2RUY7 |